Bangladesh’s top pharma group & Serum Institute of India join hands for Covid-19 vaccine

The investment amount will be treated as an advance and once the vaccine receives regulatory approvals, SII will include Bangladesh among the countries who will be the first to receive an agreed quantity of this vaccine from SII on a priority basis, according to a press release.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2EyRS81
via IFTTT